Norma Corona de la Peña

Prof. Norma Corona de la Peña

Instituto Mexicano del Seguro Social

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2019 in Cells
Verified
Journal Article
Open access
PDF file
SRSARA RODRIGUEZ-ENRIQUEZ
SARA RODRIGUEZ-ENRIQUEZ
Álvaro Marín-HernándezÁlvaro Marín-Hernández
Álvaro Marín-Hernández
JGJuan C Gallardo-Pérez
Juan C Gallardo-Pérez
SPSilvia Cecilia Pacheco-Velázquez
Silvia Cecilia Pacheco-Velázquez
JBJavier Alejandro Belmont-Díaz
Javier Alejandro Belmont-Díaz
RMRafael Moreno-Sanchez
Rafael Moreno-Sanchez
Cancer development, growth, and metastasis are highly regulated by several transcription regulators (TRs), namely transcription factors, oncogenes, tumor-suppressor genes, and protein kinases. Although TR roles in these events have been well characterized, their functions in regulating other important cancer cell processes, such as metabolism, have not been systematically examined. In this review, we describe, analyze, and strive to reconstruct the regulatory networks of several TRs acting in the energy metabolism pathways, glycolysis (and its main branching reactions), and oxidative phosphorylation of nonmetastatic and metastatic cancer cells. Moreover, we propose which possible gene targets might allow these TRs to facilitate the modulation of each energy metabolism pathway, depending on the tumor microenvironment.

5 July 2018 in Viruses
Verified
Journal Article
Open access
PDF file
DNDaniel Nuñez
Daniel Nuñez
MMManuel Alejandro Mosso-Pani
Manuel Alejandro Mosso-Pani
LUVIA ENID SANCHEZ-TORRESLUVIA ENID SANCHEZ-TORRES
LUVIA ENID SANCHEZ-TORRES
MCMaría Eugenia Castro-Mussot
María Eugenia Castro-Mussot
NPNorma Corona de la Peña
Norma Corona de la Peña
MSMa Isabel Salazar
Ma Isabel Salazar
Platelets are considered as significant players in innate and adaptive immune responses. The adhesion molecules they express, including P-selectin, CD40L, and CD42b, facilitate interactions with many cellular effectors. Upon interacting with a pathogen, platelets rapidly express and enhance their adhesion molecules, and secrete cytokines and chemokines. A similar phenomenon occurs after exposure of platelets to thrombin, an agonist extensively used for in vitro activation of these cells. It was recently reported that the dengue virus not only interacts with platelets but possibly infects them, which triggers an increased expression of adhesion molecule P-selectin as well as secretion of IL-1β. In the present study, surface molecules of platelets like CD40L, CD42b, CD62P, and MHC class I were evaluated at 4 h of interaction with dengue virus serotype 2 (DENV-2), finding that DENV-2 induced a sharp rise in the membrane expression of all these molecules. At 2 and 4 h of DENV-2 stimulation of platelets, a significantly greater secretion of soluble CD40L (sCD40L) was found (versus basal levels) as well as cytokines such as GM-CSF, IL-6, IL-8, IL-10, and TNF-α. Compared to basal, DENV-2 elicited more than two-fold increase in these cytokines. Compared to the thrombin-induced response, the level generated by DENV-2 was much higher for GM-CSF, IL-6, and TNF-α. All these events induced by DENV end up in conspicuous morphological changes observed in platelets by confocal microscopy and transmission electron microscopy, very different from those elicited by thrombin in a more physiological scenery.
1

17 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NPNorma Corona de la Peña
Norma Corona de la Peña
MGManuel Gutierrez-Aguilar
Manuel Gutierrez-Aguilar
IHIleana Hernández-Reséndiz
Ileana Hernández-Reséndiz
Álvaro Marín-HernándezÁlvaro Marín-Hernández
Álvaro Marín-Hernández
SRSARA RODRIGUEZ-ENRIQUEZ
SARA RODRIGUEZ-ENRIQUEZ
Thrombin-induced platelet activation requires substantial amounts of ATP. However, the specific contribution of each ATP-generating pathway i.e., oxidative phosphorylation (OxPhos) versus glycolysis and the biochemical mechanisms involved in the thrombin-induced activation of energy metabolism remain unclear. Here we report an integral analysis on the role of both energy pathways in human platelets activated by several agonists, and the signal transducing mechanisms associated with such activation. We found that thrombin, Trap-6, arachidonic acid, collagen, A23187, epinephrine and ADP significantly increased glycolytic flux (3–38 times vs. non-activated platelets) whereas ristocetin was ineffective. OxPhos (33 times) and mitochondrial transmembrane potential (88%) were increased only by thrombin. OxPhos was the main source of ATP in thrombin-activated platelets, whereas in platelets activated by any of the other agonists, glycolysis was the principal ATP supplier. In order to establish the biochemical mechanisms involved in the thrombin-induced OxPhos activation in platelets, several signaling pathways associated with mitochondrial activation were analyzed. Wortmannin and LY294002 (PI3K/Akt pathway inhibitors), ristocetin and heparin (GPIb inhibitors) as well as resveratrol, ATP (calcium-release inhibitors) and PP1 (Tyr-phosphorylation inhibitor) prevented the thrombin-induced platelet activation. These results suggest that thrombin activates OxPhos and glycolysis through GPIb-dependent signaling involving PI3K and Akt activation, calcium mobilization and protein phosphorylation.

1 August 2005 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
NPNorma Corona de la Peña
Norma Corona de la Peña
SUSalvador Uribe-Carvajal
Salvador Uribe-Carvajal
RBRehotbeverly Barrientos-Rios
Rehotbeverly Barrientos-Rios
LMLisnet Matias-Aguilar
Lisnet Matias-Aguilar
GMGuadalupe Montiel-Manzano
Guadalupe Montiel-Manzano
AMAbraham Majluf-Cruz
Abraham Majluf-Cruz
Platelet aggregation is inhibited by the polyamines putrescine, spermidine, and spermine. To date, the mechanism of action has not been clearly identified. Evidence suggests that polyamines may interact with the fibrinogen receptor (GP IIb/IIIa), interfering with platelet-platelet attachment. The effect of polyamines on human platelet aggregation and GP IIb/IIIa activation was evaluated. For the aggregation experiments, platelets were obtained from heparin- or citrate-collected blood. Our results indicate that the polyamines putrescine, spermidine, and spermine cause a dose-dependent inhibition of ADP- or collagen-mediated platelet aggregation with an order of potency spermine>spermidine>putrescine. In addition, spermine arrests or inhibits thrombin-, epinephrine-, arachidonate-, or ristocetin-induced platelet aggregation. Expression of platelet membrane glycoproteins IIb, IIIa, and IX is not reduced by polyamines. However, spermine inhibits the ADP- or thrombin-induced activation of GP IIb/IIIa. It is concluded that the final step in aggregation, common to all agonists, ie, fibrinogen binding to GP IIb/IIIa, is inhibited by spermine through inhibition of the agonist-induced activation of GP IIb/IIIa that precedes fibrinogen-ligand binding.

1 October 2003
Verified
Journal Article
Closed access
GMGuadalupe Montiel-Manzano
Guadalupe Montiel-Manzano
APAurora De La Peña-Díaz
Aurora De La Peña-Díaz
AMAbraham Majluf-Cruz
Abraham Majluf-Cruz
GCGabriela Cesarman-Maus
Gabriela Cesarman-Maus
NPNorma Corona de la Peña
Norma Corona de la Peña
ARAurelia Virginia Reyes-Núñez
Aurelia Virginia Reyes-Núñez